Skip to main content
SpringerLink
Log in

Mycophenolat Mofetil als Remissionsinduktion bei M. Wegener

Mycophenolate mofetil for induction of remission in Wegener’s granulomatosis

  • Klinische Studien kurzgefasst
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Groot K de, Rasmussen N, Bacon PA et al. (2005) Randomised trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vascultits. Arthritis Rheum 52: 2461–2469

    Article  PubMed  Google Scholar 

  2. Omdal R, Wildhagen K, Hansen T et al. (2005) Anti-CD20 therapy of tretment-resistant Wegener’s granulomatosis: favorable but temporary response. Scand J Rheumatol 34: 229–232

    Article  PubMed  CAS  Google Scholar 

  3. Smith KG, Jones RB, Burns SM, Jayne DR (2006) Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment. Arthritis Rheum 54: 2970–2982

    Article  PubMed  CAS  Google Scholar 

  4. Birck R, Warnatz K, Lorenz HM et al. (2003) 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy. J Am Soc Nephrol 14: 440–447

    Article  PubMed  CAS  Google Scholar 

  5. Benenson E, Fries JW, Heilig B et al. (2005) High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener’s granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide. Clin Rheumatol 24: 251–257

    Article  PubMed  CAS  Google Scholar 

  6. Jayne DR, Chapel H, Adu D et al. (2000) Intravenous immunoglobulin for ANCA associated systemic vasculitis with persistent disease activity. QJM 93: 433–439

    Article  PubMed  CAS  Google Scholar 

  7. Metzler C, Fink C, Lamprecht P et al. (2004) Maintenance of remisison with leflunomide in Wegener’s granulomatosis. Rheumatology 43: 315–320

    Article  PubMed  CAS  Google Scholar 

  8. Henes JC, Fritz J, Koch S et al. (2007) Rituximab for treatment-resistant extensive Wegener’s granulomatosis – additive effects of a maintenance treatment with leflunomide. Clin Rheumatol [Epub ahead of print, May 15]

  9. Koldingsness W, Nossent JC (2003) Baseline features and initial treatment as predictors of remisison or relapse in Wegener’s granulomatosis. J Rheumatol 30: 80–88

    Google Scholar 

Download references

Interessenkonflikt

Der korrespondierend Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Abteilung Innere Medizin II (Hämatologie, Onkologie, Immunologie, Rheumatologie, Pulmologie), Medizinische Universitätsklinik Tübingen, Otfried-Müller-Straße 10, 72076, Tübingen, Deutschland

    I. Kötter

Authors
  1. I. Kötter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Kötter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kötter, I. Mycophenolat Mofetil als Remissionsinduktion bei M. Wegener. Z. Rheumatol. 66, 441–443 (2007). https://doi.org/10.1007/s00393-007-0194-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-007-0194-0

Search

Navigation